Company intelligence / Profile preview

MDxK

United States / Belgium / International presence via partnershipszoominfo.com ↗

Ownership: Private
Development stage: Other

Overview

MDxhealth offers clinically validated molecular diagnostic tests for prostate cancer and urologic diseases. Their tests are used to personalize diagnosis and treatment decisions in clinical practice. The company has established collaborations with academic centers to validate its products. No drug or therapeutic clinical trial results; focus on commercialized diagnostics. Key product(s) include ConfirmMDx® for prostate cancer risk assessment. Clinical studies have demonstrated improved detection of aggressive prostate cancers compared to standard methods.

Therapeutic areas: OncologyMen's Health
Modalities: Diagnostic test (Molecular diagnostic)Epigenetic assayGenetic assay
Industry: Molecular Diagnostics

Partnerships

Collaborations with international academic institutes and medical centers; specific partners not listed by name in the available sources.

Beyond the preview

Go deeper on MDxK.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MDxK.

Explore the full profile